Original post:
GreenLight Biosciences announces $109 million financing
Author Archives: Fredricko
Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
Continue reading here:
Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Spectral Announces Second Quarter Results and Provides Corporate Update
Bespoke Extracts to Expand its Colorado Business and Capabilities with Acquisition of Best Day Ever
SciSparc Issued Israeli Patent for its Core Technology for Treating Central Nervous Systems Disorders
Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
PepGen Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
VYNE Therapeutics Reports Second Quarter 2022 Financial Results
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Palisade Bio Announces Pricing of $12 Million Upsized Underwritten Public Offering
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine…
POINT Biopharma Reports Second Quarter 2022 Financial Results and Provides Business Highlights
Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business Update
Clene to Host VISIONARY-MS Results Call and Webcast on August 15
Read this article:
Clene to Host VISIONARY-MS Results Call and Webcast on August 15
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
View original post here:
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates
IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
See the rest here:
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders
Read the original here:
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders